Sandra Dross

484 total citations
17 papers, 297 citations indexed

About

Sandra Dross is a scholar working on Virology, Infectious Diseases and Immunology. According to data from OpenAlex, Sandra Dross has authored 17 papers receiving a total of 297 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Virology, 13 papers in Infectious Diseases and 4 papers in Immunology. Recurrent topics in Sandra Dross's work include HIV Research and Treatment (16 papers), HIV/AIDS Research and Interventions (13 papers) and HIV/AIDS drug development and treatment (12 papers). Sandra Dross is often cited by papers focused on HIV Research and Treatment (16 papers), HIV/AIDS Research and Interventions (13 papers) and HIV/AIDS drug development and treatment (12 papers). Sandra Dross collaborates with scholars based in United States, Kenya and Mozambique. Sandra Dross's co-authors include Lisa M. Frenkel, Ingrid A. Beck, Soren Gantt, Helen Horton, Ana Gervassi, Samah R. Sakr, Heather B. Jaspan, Michael H. Chung, Amanda Jacobson and Mark A. Micek and has published in prestigious journals such as The Journal of Immunology, PLoS ONE and Clinical Infectious Diseases.

In The Last Decade

Sandra Dross

17 papers receiving 294 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sandra Dross United States 11 191 171 85 42 23 17 297
Erin A. Goecker United States 5 210 1.1× 120 0.7× 48 0.6× 40 1.0× 35 1.5× 17 262
Nina Orlova-Fink Switzerland 3 217 1.1× 193 1.1× 118 1.4× 114 2.7× 15 0.7× 5 331
Julie Frouard United States 8 210 1.1× 61 0.4× 111 1.3× 57 1.4× 59 2.6× 12 343
Djibril Wade Senegal 9 209 1.1× 104 0.6× 41 0.5× 69 1.6× 25 1.1× 13 295
Ria Goswami United States 9 115 0.6× 66 0.4× 104 1.2× 89 2.1× 52 2.3× 19 300
Qingxia Zhao China 9 154 0.8× 139 0.8× 66 0.8× 55 1.3× 23 1.0× 32 266
Diana B. Schramm South Africa 10 167 0.9× 258 1.5× 199 2.3× 56 1.3× 27 1.2× 16 378
Glenda Canderan United States 9 78 0.4× 64 0.4× 118 1.4× 34 0.8× 42 1.8× 16 219
Rasmus Offersen Denmark 5 67 0.4× 93 0.5× 152 1.8× 75 1.8× 38 1.7× 6 250
L.‐M. Yindom United Kingdom 11 96 0.5× 142 0.8× 208 2.4× 86 2.0× 43 1.9× 46 345

Countries citing papers authored by Sandra Dross

Since Specialization
Citations

This map shows the geographic impact of Sandra Dross's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sandra Dross with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sandra Dross more than expected).

Fields of papers citing papers by Sandra Dross

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sandra Dross. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sandra Dross. The network helps show where Sandra Dross may publish in the future.

Co-authorship network of co-authors of Sandra Dross

This figure shows the co-authorship network connecting the top 25 collaborators of Sandra Dross. A scholar is included among the top collaborators of Sandra Dross based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sandra Dross. Sandra Dross is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Dross, Sandra, Shabnum Patel, Meei‐Li Huang, et al.. (2023). Efficient ex vivo expansion of conserved element vaccine-specific CD8+ T-cells from SHIV-infected, ART-suppressed nonhuman primates. Frontiers in Immunology. 14. 1188018–1188018. 2 indexed citations
2.
O’Connor, Megan A., Sandra Dross, Debbie Bratt, et al.. (2021). Effects of therapeutic vaccination on the control of SIV in rhesus macaques with variable responsiveness to antiretroviral drugs. PLoS ONE. 16(6). e0253265–e0253265. 9 indexed citations
3.
O’Connor, Megan A., Sandra Dross, Thomas B. Lewis, et al.. (2021). A Gut Reaction to SIV and SHIV Infection: Lower Dysregulation of Mucosal T Cells during Acute Infection Is Associated with Greater Viral Suppression during cART. Viruses. 13(8). 1609–1609. 1 indexed citations
4.
Beck, Ingrid A., Christine J. McGrath, Sandra Dross, et al.. (2020). Pre-treatment HIV-drug resistance associated with virologic outcome of first-line NNRTI-antiretroviral therapy: A cohort study in Kenya. EClinicalMedicine. 18. 100239–100239. 20 indexed citations
6.
Chung, Michael H., Christine J. McGrath, Ingrid A. Beck, et al.. (2019). Evaluation of the management of pretreatment HIV drug resistance by oligonucleotide ligation assay: a randomised controlled trial. The Lancet HIV. 7(2). e104–e112. 13 indexed citations
7.
Beck, Ingrid A., Christine J. McGrath, Sandra Dross, et al.. (2019). Pre-Treatment HIV-Drug Resistance Associated with Virologic Outcome of First-Line NNRTI-Antiretroviral Therapy: A Cohort Study in Kenya. SSRN Electronic Journal. 2 indexed citations
8.
Chung, Michael H., Ingrid A. Beck, Nelly Yatich, et al.. (2016). Increasing HIV-1 pretreatment drug resistance among antiretroviral-naïve adults initiating treatment between 2006 and 2014 in Nairobi, Kenya. AIDS. 30(10). 1680–1682. 15 indexed citations
10.
Gervassi, Ana, Sandra Dross, Amanda Jacobson, et al.. (2014). Myeloid Derived Suppressor Cells Are Present at High Frequency in Neonates and Suppress In Vitro T Cell Responses. PLoS ONE. 9(9). e107816–e107816. 73 indexed citations
11.
Mitchell, Caroline M., Sandra Dross, Ingrid A. Beck, Mark A. Micek, & Lisa M. Frenkel. (2014). Low Concentrations of HIV-1 DNA at Birth Delays Diagnosis, Complicating Identification of Infants for Antiretroviral Therapy to Potentially Prevent the Establishment of Viral Reservoirs. Clinical Infectious Diseases. 58(8). 1190–1193. 19 indexed citations
12.
Micek, Mark A., Sandra Dross, Ingrid A. Beck, et al.. (2014). Transmission of Nevirapine-Resistant HIV Type 1 via Breast Milk to Infants After Single-Dose Nevirapine in Beira, Mozambique. The Journal of Infectious Diseases. 210(4). 641–645. 10 indexed citations
13.
Chung, Michael H., Ingrid A. Beck, Sandra Dross, et al.. (2014). Oligonucleotide Ligation Assay Detects HIV Drug Resistance Associated With Virologic Failure Among Antiretroviral-Naive Adults in Kenya. JAIDS Journal of Acquired Immune Deficiency Syndromes. 67(3). 246–253. 23 indexed citations
14.
Vaz, Louise E., et al.. (2013). Simultaneous and sensitive detection of human immunodeficiency virus type 1 (HIV) drug resistant genotypes by multiplex oligonucleotide ligation assay. Journal of Virological Methods. 192(1-2). 39–43. 8 indexed citations
15.
Micek, Mark A., Ingrid A. Beck, Sandra Dross, et al.. (2012). Effects of Short-Course Zidovudine on the Selection of Nevirapine-Resistant HIV-1 in Women Taking Single-Dose Nevirapine. The Journal of Infectious Diseases. 205(12). 1811–1815. 8 indexed citations
16.
Soria, Jaime, Marta E. Bull, Caroline M. Mitchell, et al.. (2011). Transmitted HIV Resistance to First-Line Antiretroviral Therapy in Lima, Peru. AIDS Research and Human Retroviruses. 28(4). 333–338. 16 indexed citations
17.
Micek, Mark A., Ingrid A. Beck, Sandra Dross, et al.. (2010). Nevirapine Resistance by Timing of HIV Type 1 Infection in Infants Treated with Single‐Dose Nevirapine. Clinical Infectious Diseases. 50(10). 1405–1414. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026